Across TCGA pan-cancer cohorts, LNCNEF RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LNCNEF’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where LNCNEF RNA is repressed in tumor relative to normal tissue. In most cancer types LNCNEF is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.
THCA and LIHC are the cancer types where LNCNEF tumor–normal differential expression is most reproducible.